2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-en-1-one, 98%, 250mg

4-Bromo-1-(fluoromethyl)-2-methylbenzene, 97.0%, 100mg

2-Methylpyridine-4-boronic acid, 95.0%, 25g

(R)-3-((tert-Butoxycarbonyl)amino)-2-phenylpropanoic acid, 95.0%, 100mg

6,7-DIHYDRO-2H-BENZO[6,7]CYCLOHEPTA[1,2-C]PYRIDAZIN-3(5H)-ONE, 95.0%, 2g

2-(4-Bromophenyl)-2-oxoacetaldehyde, 95.0%, 250mg

N-acetil-D-glucosamina, mínimo 98 %, para bioquímica, 5 g, envase de plástico.

(4S,5R)-2-(6-METHYLPYRIDIN-2-YL)-4,5-DIPHENYL-4,5-DIHYDROOXAZOLE, 95%, 250mg

t-Boc-N-amido-PEG5-acetic acid, 25g

2-{5-[4-Amino-2-fluoro-5-nitro-3-(oxolan-2-yl)phenyl]pyrimidin-2-yl}propan-2-ol, 98%, 1g

2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonyl chloride, 95.0%, 500mg

[1-(2,2-difluoroethyl)azetidin-3-yl]methanol, 95.0%, 250mg

8-Bromo-3-(3-bromopyridin-2-yl)imidazo[1,5-a]pyridine, 5g